- Robert C. Green, MD, MPH
- Kurt Christensen, PhD
- Heidi Rehm, PhD, FACMG
- Daiva Nielsen, PhD
- Lily Hoffman-Andrews
- Rebecca Walsh
- Ozge Ceyhan-Birsoy, PhD
The Genomes2People team and our collaborators presented data from a number of our key projects at the American College of Medical Genetics and Genomics (ACMG) 2016 Annual Clinical Genetics Meeting from March 8 to 12 in Tampa, FL.
Wednesday, March 9
8:00am-9:30am: G2P director Robert C. Green, MD, MPH, will present as part of the Satellite Symposium “The Rising Tide of Patient Initiated Testing: What are the Consequences for Patients and Health Professionals?” at the Marriott Tampa Waterside in Grand Ballroom A-E.
- Dr. Green will present on “Personal Genome Testing: Comprehension and Consequences.”
Thursday, March 10
10:30am-12:00pm: G2P team members and collaborators will be presenting posters with data from G2P projects in the East Exhibit Hall.
- Kurt Christensen, PhD, Instructor at Brigham & Women’s and Harvard Medical School, will present data from the MedSeq Project in his poster “Using Whole Genome Sequencing to Motivate Lifestyle Changes: Preliminary Findings from the MedSeq Project” (663).
- Lily Hoffman-Andrews, Research Assistant, will also present data from MedSeq in her poster “The Association of Monogenic Findings from Whole Genome Sequencing with Known Phenotypes: 4 Case Studies” (259).
- Rebecca Walsh, Research Assistant, will present data from the BabySeq Project in her poster “Experiences and Lessons from the BabySeq Project about Parents’ Interest in Newborn Genomic Sequencing” (473).
- Yue Guan, MS, CGC, a G2P collaborator, will present data from the REVEAL Study in her poster “Disclosing Genetic Risk of Alzheimer’s Disease to Cognitively Impaired Patients and Visit Companions: Findings from The REVEAL Study” (445).
4:15pm – 5:45pm: Dr. Green will present as part of the Robert C. Baumiller Symposium “Pro/Con: The Debate Around Direct-Access-Testing” in the Central Exhibit Hall.
- Dr. Green will present the perspective “Emerging Empirical Data Show No Evidence of Harm.”
Friday, March 11
10:30am – 12:00pm: G2P team members and collaborators will be presenting posters with data from G2P projects in the East Exhibit Hall.
- Daiva Nielsen, PhD, post-doctoral research fellow with G2P, will present data from the PeopleSeq Consortium in her poster “Health Information-seeking as a Result of Predispositional Genome Sequencing: Findings from the PeopleSeq Consortium” (228).
- J. Scott Roberts, PhD, a G2P collaborator, will present data from MedSeq in his poster “Patient Understanding and Satisfaction Regarding the Clinical Use of Whole Genome Sequencing: Findings from the MedSeq Project” (430).
- Allison Cirino, MS, CGC, a G2P collaborator, will present data from MedSeq in her poster “Investigating the Utility of Whole Genome Sequencing in Hypertrophic Cardiomyopathy Patients” (510).
- Heidi Rehm, PhD, a G2P collaborator, will present data from the CSER Consortium, of which MedSeq is a part, in her poster “Performance of the ACMG/AMP Variant Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research (CSER) Consortium” (482).
3:45pm – 4:00pm: G2P collaborator Ozge Birsoy, PhD, will present data from BabySeq as part of a platform presentation session on whole exome sequencing in Ballroom AB.
- Dr. Birsoy will present her abstract “Genomic Sequencing in Newborns: Early Sequencing Results from the BabySeq Project.”